Anophthalmia and Microphthalmia may occur during development of the eye at various stages of growth of the optic vesicle. The prevalence of this disease is considered rare. It is important to recognize microphthalmia because the development of the orbital region, as well as the lids and the fornices. The Global Anophthalmia and Microphthalmia Market is expected to grow at a CAGR of ~5.8 % during the forecast period 2018-2023.
Anophthalmia and Microphthalmia Market – Key Players
Some of key the players in the market are:
- Bristol-Myers Squibb Company
- Aerie Pharmaceuticals Inc.
- Pfizer Inc.
- Valeant Pharmaceuticals International Inc.
- Bayer AG
- Genentech Inc.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Shire and Santen Pharmaceutical Co. Ltd.
Anophthalmia and Microphthalmia Market – Overview
The major causes may include genetic mutations and abnormal chromosomes. Exposure to X-rays, chemicals, drugs, pesticides, toxins, radiation, or viruses, increases the risk of anophthalmia and microphthalmia. Anophthalmia and microphthalmia lead to optic disc dysplasia as well as non-ocular features like mental retardation, neurological abnormalities, and facial dysmorphisms.
The global anophthalmia and microphthalmia market growth is majorly attributed to the increasing prevalence of the genetic disorders and eye-related disorders. Moreover, the increasing mental retardation, neurological abnormalities are expected to drive the market growth over the assessment period.
According to the World Health Organization (WHO), an estimated 253 million people live with vision impairment 36 million are blind and 217 million have moderate to severe vision impairment worldwide. An estimated 19 million children (below age 15) are vision impaired.
Furthermore, According to the WHO estimates, neurological abnormalities are responsible for 4.5%-11% of all illnesses including low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.
However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.
Increasing prevalence of rare diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period 2017-2023.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4724 .
Anophthalmia and Microphthalmia Market – Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Government Research Institute
- Academic Institutes and Universities
- Medical Research Laboratories
- Market Research and Consulting Service Providers
- Potential Investors
Anophthalmia and Microphthalmia Market – Segmentation
The Global Anophthalmia and Microphthalmia Market is segmented on the basis by diagnosis, by treatment, and by end user. On the basis of diagnosis, it is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others. On the basis of treatment, it is segmented into surgery, and others. On the basis of end user, it is segmented into hospitals & clinics, research centers, and others.
Anophthalmia and Microphthalmia Market – Regional Analysis
The Americas dominate the global anophthalmia and microphthalmia market owing to the presence of huge patient population with eye related problems, neurological disabilities, high healthcare spending, and increasing government support for research & development.
Europe holds the second largest share of the global anophthalmia and microphthalmia market as result of increasing focus of various government agencies on the treatment of rare diseases such as acquired aplastic anemia. Moreover, the growing public awareness about anophthalmia and microphthalmia likely to boost the Europe market. According to reports from European Association for Vision and Eye Research, cases of anophthalmia and microphthalmia were identified, with a rate of 3.21 per 10,000 live births. Of which the eye defects were isolated in 5 cases (5.2%), and 24 cases (25.0%) had confirmed chromosomal abnormalities.
Asia Pacific is the fastest growing anophthalmia and microphthalmia market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.
The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4724 .
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
List of Tables
Table 1 Anophthalmia and Microphthalmia Industry Synopsis, 2017-2023
Table 2 Global Anophthalmia and Microphthalmia Market Estimates and Forecast, 2017-2023, (USD Million)
Table 3 Global Anophthalmia and Microphthalmia Market by Region, 2017-2023, (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Segmentation for Global Anophthalmia and Microphthalmia Market
Figure 3 Segmentation Market Dynamics for Anophthalmia and Microphthalmia Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312